References and Notes
-
1a
Tsang JW.
Schmied B.
Nyfeler R.
Goodman M.
J.
Med. Chem.
1984,
27:
1663
-
1b
Gershonov E.
Granoth R.
Tzehoval E.
Gaoni Y.
Fridkin M.
J.
Med. Chem.
1996,
39:
4833
-
2a
Gatos M.
Formaggio F.
Crisma M.
Toniolo C.
Bonora GM.
Benedetti Z.
Di Blasio B.
Iacovino R.
Santini A.
Saviano M.
Kamphuis J.
J. Pept. Sci.
1997,
3:
110
-
2b
Jiménez-Osés G.
Corzana F.
Busto JH.
Pérez-Fernández M.
Peregrina JM.
Avenoza A.
J. Org. Chem.
2006,
71:
1869
- 3
Robins LI.
Dixon SM.
Wilson DK.
Kurth MJ.
Bioorg.
Med. Chem.
2006,
14:
7728
- 4
Wrobleski ML.
Reichard GA.
Paliwal S.
Shah S.
Tsui H.-C.
Duffy RA.
Lachowicz JE.
Morgan CA.
Varty GB.
Shih N.-Y.
Bioorg.
Med. Chem. Lett.
2006,
16:
3859
- 5
Gaoni Y.
Chapman AG.
Parvez N.
Pook PC.-K.
Jane DE.
Watkins JC.
J.
Med. Chem.
1994,
37:
4288
- 6
Allan RD.
Hanrahan JR.
Hambley TW.
Johnston
GAR.
Mewett KN.
Mitrovic AD.
J. Med. Chem.
1990,
33:
2905
- 7
Kabalka GW.
Yao M.-L.
J. Org. Chem.
2004,
69:
8280
-
8a
Martarello L.
McConathy J.
Camp VM.
Malveaux EJ.
Simpson NE.
Simpson CP.
Olson JJ.
Bowers GD.
Goodman MM.
J. Med. Chem.
2002,
45:
2250
-
8b
Shoup TM.
Goodman MM.
J.
Labelled Compd. Radiopharm.
1999,
42:
215
-
8c Goodman MM. inventors;
WO 2007001940 A2 20070104.
-
9a
O’Hagan D.
Rzepa HS.
Chem. Commun.
1997,
645
-
9b
Kirsch P. In Modern Fluoroorganic Chemistry
Wiley-VCH;
Weinheim:
2004.
- 10
Gallucci RR.
Going R.
J. Org. Chem.
1981,
46:
2532
-
11a
Perkin WH.
Ber. Dtsch. Chem.
Ges.
1883,
16:
1787
-
11b
Perkin WH.
Ber. Dtsch. Chem. Ges.
1884,
17:
54
-
11c
Pigou PE.
Schiesser CH.
J.
Org. Chem.
1988,
53:
3841
-
12a Bergs H. inventors; DE 566094.
; Chem. Abstr. 1933, 27: 1001
-
12b
Bucherer HR.
Barsch H.
J. Prakt.
Chem.
1934,
140:
151
- 13
Dmowski W.
Houben-Weyl Methods of Organic Chemistry
Vol.
E10a:
Baasner B.
Hagemann H.
Tatlow JC.
Thieme;
Stuttgart:
1999.
p.321
14
Spectral and Analytical
Data for New Compounds
Diisopropyl
3-Oxo-1,1-cyclobutanedicarboxylate (10)
¹H
NMR (400 MHz, CDCl3): δ = 5.10 [m, J = 6.4 Hz,
2 H, CH(CH3)2],
3.58 (s, 4 H, CH2), 1.26 [d, J = 6.4
Hz, 12 H, CH(CH
3)2]. ¹³C
NMR (100 MHz, CDCl3): δ = 200.95 (s, CH2
CO), 169.64 (s, COO), 69.66 [s, CH(CH3)2],
54.98 (s, CH2CO), 43.54 [s, C(COOi-Pr)2],
21.14 [s, CH(CH3)2].
MS: m/z = 243 [M + 1].
Diisopropyl 6,8-Dioxo-5,7-diazaspiro[3.4]octane-2,2-dicarboxylate
(11)
Mp 142-143 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 8.75
(br s, 1 H, NH), 6.69 (s, 1 H, NH), 5.03 [m, 2 H, CH(CH3)2], 3.14 (d, J = 13.6
Hz, 2 H, CH2), 2.63 (d, J = 13.6
Hz, 2 H, CH2), 1.18 [2
overlapped d, J = 6.4
Hz, 12 H, CH(CH
3)2]. ¹³C
NMR (100 MHz, CDCl3): δ = 175.70 (s,
CCONH), 172.22 (s, COO), 169.20 (s, COO),
156.08 (s, NHCONH), 70.64 [s, CH(CH3)2],
69.55 [s, CH(CH3)2],
58.16 (s, NHCCO), 46.72 (s, CH2),
41.98 [s, C(COOi-Pr)2],
39.14 (s, CH2), 21.68 [s, CH(CH3)2],
21.63 [s, CH(CH3)2].
MS: m/z = 313 [M + 1].
2,2-Bis(trifluoromethyl)-5,7-diazaspiro[3.4]octane-6,8-dione
(13)
Mp >230 ˚C. ¹H
NMR [500 MHz, (CD3)2SO]: δ = 10.88
(s, 1 H, NH), 8.59 (s, 1 H, NH), 3.14 (d, J = 12.0
Hz, 2 H, CH2), 2.69 (d, J = 12.0 Hz,
2 H, CH2). ¹9F NMR [377
MHz, (CD3)2SO]: δ = -71.72
(q, 4
J
F-F = 7.4
Hz, CF3), -73.13 (q, 4
J
F-F = 7.4
Hz, CF3). ¹³C NMR [125
MHz, (CD3)2SO]: δ = 176.23
(s, CCONH), 157.14 (s, NHCONH), 126.87
(q, ¹
J
C-F = 280.0
Hz, CF3), 125.15 (q, ¹
J
C-F = 277.5
Hz, CF3), 55.52 (s, NHCCO),
42.73 [m, C(CF3)2],
33.79 (s, CH2). MS: m/z = 277 [M + 1].
1-Amino-3,3-bis(trifluoromethyl)cyclobutanaminium
Chloride (6)
Mp >230 ˚C. ¹H
NMR [400 MHz, (CD3)2SO]: δ = 3.21
(d, J = 16.0
Hz, 2 H, CH2), 3.07 (d, J = 16.0 Hz,
2 H, CH2). ¹9F NMR [377
MHz, (CD3)2SO]: δ = -67.21
(q, 4
J
F-F = 7.4
Hz, CF3), -67.49 (q, 4
J
F-F = 7.4
Hz, CF3). ¹³C NMR [100
MHz, (CD3)2SO]: δ = 173.35
(s, COOH), 125.15 (q, ¹
J
C-F = 273.0 Hz,
CF3), 124.65 (q, ¹
J
C-F = 272.4
Hz, CF3), 53.35 (s, NHCCO), 40.39 [m, C(CF3)2],
31.81 (s, CH2). MS: m/z = 252 [M
- Cl].
cis
-2-(Trifluoromethyl)-5,7-diazaspiro[3.4]octane-6,8-dione
(16a)
Mp >230 ˚C. ¹H
NMR [400 MHz, (CD3)2SO]: δ = 10.76
(s, 1 H, NH), 8.41 (s, 1 H, NH), 3.05 (m, 1 H, CHCF3),
2.58 (pseudo t, J = 10.0
Hz, 2 H, CH2), 2.35 (pseudo
t, J = 10.0 Hz,
2 H, CH2). ¹9F NMR [377
MHz, (CD3)2SO]: δ = -72.46 (d, ³
J
H-F = 11.3
Hz, CF3). ¹³C NMR [100
MHz, (CD3)2SO]: δ = 178.26
(s, CCONH), 156.34 (s, NHCONH), 127.02
(q, ¹
J
C-F = 274.0
Hz, CF3), 56.73 (s, NHCCO),
32.46 (q,
³
J
C-F = 3.0
Hz, CH2), 28.86 (q, ²
J
C-F = 32.0
Hz, CHCF3).
MS: m/z = 209 [M + 1].
cis
-1-Carboxy-3-(trifluoromethyl)cyclobutanaminium Chloride
(7)
Mp >230 ˚C. ¹H
NMR (400 MHz, D2O): δ = 3.26 (m, 1
H, CHCF3), 2.64 (pseudo t, J = 12.8,
8.8 Hz, 2 H, CH2), 2.48 (pseudo
t, J = 10.0
Hz, 2 H, CH2). ¹9F NMR (377 MHz, D2O): δ = -76.53
(d, ³
J
H-F = 7.5
Hz, CF3). ¹³C NMR (100 MHz,
D2O): δ = 174.40 (s, COOH), 125.10
(q, ¹
J
C-F = 273.0 Hz,
CF3), 52.26 (s, NHCCO), 29.39
(q, ²
J
C-F = 32.0
Hz, CHCF3), 28.80 (q, ³
J
C-F = 3.0
Hz, CH2). MS: m/z = 184 [M -Cl].